Acquired factor VIII inhibitor and subsequent development of non-Hodgkin's lymphoma: a case report and review of the literature
Clinical and laboratory staff should be alert to the possibility of such an event when the medical history of patients is enriched with new symptoms or signs. A follow-up of at least 2 years might therefore be required.
Document Type: Research Article
Affiliations: 1: Internal Medicine and Haemocoagulopathies Unit 2: Intensive Care Unit 3: Vascular Surgery Unit, Policlinico Universitario ‘Duilio Casula’, University of Cagliari, Cagliari, Italy
Publication date: December 1, 2015